154 related articles for article (PubMed ID: 34680125)
1. Inhibition of CNOT2 Induces Apoptosis via MID1IP1 in Colorectal Cancer Cells by Activating p53.
Jung JH; Lee D; Ko HM; Jang HJ
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680125
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
Jung JH; Lee HJ; Kim JH; Sim DY; Im E; Kim S; Chang S; Kim SH
Cells; 2020 Apr; 9(4):. PubMed ID: 32316188
[TBL] [Abstract][Full Text] [Related]
3. The Antitumor Effect of Timosaponin A3 through c-Myc Inhibition in Colorectal Cancer Cells and Combined Treatment Effect with 5-FU or Doxorubicin.
Ko HM; Jee W; Park DI; Kim KI; Jung JH; Jang HJ
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233202
[TBL] [Abstract][Full Text] [Related]
4. Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells.
Park YR; Jee W; Park SM; Kim SW; Jung JH; Kim H; Kim KI; Jang HJ
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139419
[TBL] [Abstract][Full Text] [Related]
5. Ophiopogonin D increase apoptosis by activating p53
Ko HM; Jee W; Lee D; Jang HJ; Jung JH
Front Pharmacol; 2022; 13():974468. PubMed ID: 36569330
[TBL] [Abstract][Full Text] [Related]
6. CNOT2 depletion disrupts and inhibits the CCR4-NOT deadenylase complex and induces apoptotic cell death.
Ito K; Inoue T; Yokoyama K; Morita M; Suzuki T; Yamamoto T
Genes Cells; 2011 Apr; 16(4):368-79. PubMed ID: 21299754
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
Liu HF; Hsiao PW; Chao JI
Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
[TBL] [Abstract][Full Text] [Related]
8. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
9. CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells.
Sohn EJ; Jung DB; Lee H; Han I; Lee J; Lee H; Kim SH
Cancer Lett; 2018 Jan; 412():88-98. PubMed ID: 29024811
[TBL] [Abstract][Full Text] [Related]
10. CCR4-NOT2 Promotes the Differentiation and Lipogenesis of 3T3-L1 Adipocytes via Upregulation of PPARx03B3;, CEBPα and Inhibition of P-GSK3α/β and β-Catenin.
Sohn EJ; Jung DB; Lee J; Yoon SW; Won GH; Ko HS; Kim SH
Cell Physiol Biochem; 2015; 37(5):1881-9. PubMed ID: 26584287
[TBL] [Abstract][Full Text] [Related]
11. p53 interferes with microtubule-stabilizing agent-induced apoptosis in prostate and colorectal cancer cells.
Kim JY; Chung JY; Lee SG; Kim YJ; Park JE; Yun J; Park YC; Kim BG; Yoo YH; Kim JM
Int J Mol Med; 2013 Jun; 31(6):1388-94. PubMed ID: 23563592
[TBL] [Abstract][Full Text] [Related]
12. A selective p53 activator and anticancer agent to improve colorectal cancer therapy.
Ramos H; Soares MIL; Silva J; Raimundo L; Calheiros J; Gomes C; Reis F; Monteiro FA; Nunes C; Reis S; Bosco B; Piazza S; Domingues L; Chlapek P; Vlcek P; Fabian P; Rajado AT; Carvalho ATP; Veselska R; Inga A; Pinho E Melo TMVD; Saraiva L
Cell Rep; 2021 Apr; 35(2):108982. PubMed ID: 33852837
[TBL] [Abstract][Full Text] [Related]
13. Stathmin/oncoprotein 18, a microtubule regulatory protein, is required for survival of both normal and cancer cell lines lacking the tumor suppressor, p53.
Carney BK; Cassimeris L
Cancer Biol Ther; 2010 May; 9(9):699-709. PubMed ID: 20200495
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CCR4-NOT complex deadenylase activity and cellular responses by MK2-dependent phosphorylation of CNOT2.
Suzuki T; Hoshina M; Nishijima S; Hoshina N; Kikuguchi C; Tomohiro T; Fukao A; Fujiwara T; Yamamoto T
RNA Biol; 2022; 19(1):234-246. PubMed ID: 35129087
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
Zhang S; Zhou L; Hong B; van den Heuvel AP; Prabhu VV; Warfel NA; Kline CL; Dicker DT; Kopelovich L; El-Deiry WS
Cancer Res; 2015 Sep; 75(18):3842-52. PubMed ID: 26294215
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
Lu M; Wang C; Wang J
Int J Oncol; 2016 Aug; 49(2):603-10. PubMed ID: 27279458
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
Chiu SJ; Lee YJ; Hsu TS; Chen WS
Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
[TBL] [Abstract][Full Text] [Related]
18. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
19. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
[TBL] [Abstract][Full Text] [Related]
20. 8-Acetonyldihydronitidine inhibits the proliferation of human colorectal cancer cells via activation of p53.
Zhou J; Li Z; Zhang J; Wang H; Yin S; Du J
Eur J Pharmacol; 2019 Jul; 854():256-264. PubMed ID: 30928633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
